Dickerman R M, Gewertz B L, Foley D W, Fry W J
Surgery. 1977 May;81(5):605-9.
Intra-arterial tolazoline has been used as an adjunct for angiographers and has been investigated for application in certain peripheral vascular disorders secondary to its potent activity as a vasodilator. We have had experience with three cases in which severe peripheral arterial trauma had resulted in nonviable extremities in spite of both orthopedic manipulation and vascular reconstruction. Continuous infusions of intra-arterial tolazoline were begun with marked improvement in blood flow in all extremities and resultant viability in all three within 48 hours. All three of these extremities, although severely traumatized, had one patent vessel distal to the popliteal trifurcation which was patent and which insured at least some flow to the distal extremity. Canine experiments were performed which demonstrated that intra-arterial tolazoline increased distal limb blood flow but did not moderate muscle surface hydrogen ion increase. These experiments confirm that the most important effect of the drug is in opening of precapillary arteriovenous shunts in the skin which increase total blood flow in medium and large size blood vessels in the injured limb. Major systemic effects of the drug were not observed when used in these specified concentrations and when monitored carefully by nursing personnel. We therefore feel that infusion of tolazoline can be used in specified cases of peripheral arterial trauma when both orthopedic and vascular reconstruction have not restored adequate blood flow to the traumatized extremity.
动脉内注射妥拉唑啉已被血管造影师用作辅助药物,并因其强大的血管舒张活性而被研究用于某些继发性外周血管疾病。我们有三例严重外周动脉创伤的病例经验,尽管进行了骨科手术操作和血管重建,但肢体仍无法存活。开始持续动脉内输注妥拉唑啉后,所有肢体的血流均有显著改善,且在48小时内所有三个肢体均恢复了存活能力。这三个肢体尽管受到严重创伤,但在腘动脉三叉分支远端均有一条通畅的血管,该血管通畅并确保至少有一些血流至远端肢体。进行了犬类实验,结果表明动脉内注射妥拉唑啉可增加远端肢体血流,但不能缓解肌肉表面氢离子增加。这些实验证实,该药物最重要的作用是打开皮肤中的毛细血管前动静脉分流,从而增加受伤肢体中、大血管的总血流量。当以这些特定浓度使用并由护理人员仔细监测时,未观察到该药物的主要全身作用。因此,我们认为,在骨科手术和血管重建均未恢复受伤肢体足够血流的特定外周动脉创伤病例中,可使用妥拉唑啉输注。